Rate control is a treatment strategy for atrial fibrillation (AFib) that uses medications to slow the heart’s pumping rate to a safer range, rather than trying to restore a normal rhythm. Instead of fixing the irregular electrical signals in the upper chambers of the heart, rate control focuses on making sure the lower chambers don’t beat too fast in response. For many people with AFib, this approach effectively reduces symptoms like palpitations, shortness of breath, and fatigue while lowering the risk of heart failure over time.
How Rate Control Works
In atrial fibrillation, the upper chambers of the heart fire chaotic electrical signals. These signals travel through a gateway called the AV node before reaching the lower chambers, which do the actual work of pumping blood. Rate control medications slow down how many of those chaotic signals make it through that gateway. The upper chambers remain in fibrillation, but the lower chambers beat at a more manageable pace.
This is fundamentally different from rhythm control, which attempts to restore and maintain a normal heart rhythm. Rate control accepts that the heart will stay in AFib and instead manages the consequences. Both strategies are valid, and large clinical trials have shown comparable long-term outcomes for many patients.
Medications Used for Rate Control
Three main classes of drugs are used to keep the heart rate in check during AFib.
- Beta blockers are the most commonly prescribed. They block stress hormones from stimulating the AV node, which slows the rate at which electrical signals pass to the lower chambers. They also reduce the heart’s overall workload.
- Non-dihydropyridine calcium channel blockers (verapamil and diltiazem) slow conduction through the AV node by a different mechanism, blocking calcium from entering heart cells. These are effective but carry an important restriction: they should not be used in people with heart failure and a weakened pumping function, because they can worsen the condition and are associated with increased mortality in that group.
- Digoxin slows the AV node but has no direct effect on the lower chambers themselves. It’s typically reserved for situations where other medications aren’t enough on their own, or when beta blockers can’t be tolerated. Digoxin has a narrow safety window, and some studies have linked it to higher mortality in AFib patients, so doctors generally aim for low blood levels when they do prescribe it.
In practice, many people end up on a combination. A beta blocker might handle the heart rate well during rest but not during activity, so digoxin could be added to help. The choice depends heavily on whether you have heart failure, how active you are, and how your body responds to each drug.
What Heart Rate Doctors Aim For
There’s been significant debate about how aggressively heart rate should be lowered. Two main approaches exist: strict control, which targets a resting heart rate below 80 beats per minute and below 110 during moderate exercise, and lenient control, which simply aims for a resting rate below 110 beats per minute.
A landmark trial called RACE II, published in the New England Journal of Medicine, settled much of this debate. Researchers randomly assigned 614 patients with permanent AFib to one strategy or the other and followed them for three years. The results were clear: lenient control was just as effective as strict control in preventing cardiovascular death, stroke, hospitalization for heart failure, and other serious events. The rate of major complications was 12.9% in the lenient group and 14.9% in the strict group, a difference that was not statistically meaningful.
What was meaningful: nearly 98% of patients in the lenient group hit their target, compared to only 67% in the strict group. Lenient control also required far fewer clinic visits to achieve. Based on these findings, current European guidelines recommend starting with a lenient target of below 110 beats per minute at rest, then tightening the goal only if you continue to feel symptoms like racing heart or fatigue.
When Rate Control Is the Preferred Strategy
Rate control tends to be favored for people with permanent AFib, where restoring normal rhythm is unlikely or has already been attempted without success. It’s also a practical first choice for older adults, people who tolerate AFib well with minimal symptoms, and those who prefer a simpler medication regimen. Rhythm control drugs can carry side effects of their own, including the paradoxical risk of triggering other heart rhythm problems, so rate control avoids that trade-off entirely.
That said, the decision isn’t always either/or. Many people receive rate control medications alongside a rhythm control strategy, since even patients undergoing rhythm restoration need their heart rate managed during episodes of AFib. Your cardiologist will weigh your age, symptom burden, heart function, and how long you’ve been in AFib when recommending an approach.
When Medications Aren’t Enough
For a small number of patients, medications fail to bring the heart rate down adequately, or they cause side effects that are difficult to live with. In these cases, a procedure called “ablate and pace” may be considered. This involves using a catheter threaded through a vein (usually in the groin) to deliver radiofrequency energy to the AV node, deliberately creating a permanent heart block. A pacemaker is implanted to take over the job of controlling the lower chambers’ beating rate.
The procedure is straightforward from the patient’s perspective and is particularly effective for elderly patients or those with significant other health conditions. It provides the most reliable rate control possible, since the pacemaker sets the heart rate precisely. The trade-off is that you become permanently dependent on the pacemaker, and the upper chambers remain in fibrillation, so blood thinners are still necessary to prevent stroke.
How Rate Control Is Monitored
Doctors typically check how well rate control is working with a standard ECG in the office, sometimes supplemented by a 24-hour Holter monitor that records your heart rhythm continuously. However, Holter monitoring has limitations. Research has shown that a single 24-hour recording catches less than 10% of episodes of poor rate control in some patients, meaning it can miss periods where the heart rate spikes above target.
People with implanted devices like pacemakers or defibrillators have a built-in advantage here, since those devices record heart rate data continuously and give doctors a much more complete picture. If you’re relying on periodic monitoring alone, paying attention to your own symptoms matters. Persistent palpitations, exercise intolerance, or worsening shortness of breath can all signal that your rate control needs adjustment, even if a snapshot ECG in the office looks fine.